Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

Pooled Data ◽

Adult Phase ◽

Faculty Opinions recommendation of Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733464902.793555355 ◽

2019 ◽

Author(s):

Richard Watkins

Keyword(s):

Clinical Trial ◽

Pseudomonas Aeruginosa ◽

Phase Iii ◽

Clinical Activity ◽

Pooled Data ◽

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dky204 ◽

2018 ◽

Vol 73 (9) ◽

pp. 2519-2523 ◽

Cited By ~ 21

Author(s):

Gregory G Stone ◽

Paul Newell ◽

Leanne B Gasink ◽

Helen Broadhurst ◽

Angela Wardman ◽

...

Keyword(s):

Clinical Trial ◽

Pseudomonas Aeruginosa ◽

Phase Iii ◽

Clinical Activity ◽

Pooled Data ◽

A design for phase II testing of anticancer agents within a phase III clinical trial

Controlled Clinical Trials ◽

10.1016/0197-2456(88)90032-3 ◽

1988 ◽

Vol 9 (2) ◽

pp. 107-118 ◽

Cited By ~ 28

Author(s):

Daniel J. Schaid ◽

James N. Ingle ◽

Sam Wieand ◽

David L. Ahmann

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Anticancer Agents ◽

Phase Iii ◽

Phase Iii Clinical Trial

Assessing the success probability of a Phase III clinical trial based on Phase II data

Contemporary Clinical Trials ◽

10.1016/j.cct.2010.08.008 ◽

2010 ◽

Vol 31 (6) ◽

pp. 620-623 ◽

Cited By ~ 7

Author(s):

Zheng Su

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Success Probability ◽

Phase Iii ◽

Phase Iii Clinical Trial

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

American Journal of Clinical Dermatology ◽

10.1007/s40257-021-00618-3 ◽

2021 ◽

Author(s):

Eric L. Simpson ◽

Jonathan I. Silverberg ◽

Audrey Nosbaum ◽

Kevin L. Winthrop ◽

Emma Guttman-Yassky ◽

...

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Phase Ii ◽

Safety Analysis ◽

Phase Iii ◽

Severe Atopic Dermatitis ◽

Clinical Trial Program

The ustekinumab safety experience in patients with moderate to severe psoriasis: Results from pooled analyses of phase II and phase III clinical trial data

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2009.11.506 ◽

2010 ◽

Vol 62 (3) ◽

pp. AB132

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Clinical Trial Data ◽

Trial Data ◽

Severe Psoriasis ◽

Phase Iii ◽

Phase Iii Clinical Trial

Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial

Neurological Research ◽

10.1080/01616412.2020.1711648 ◽

2020 ◽

Vol 42 (4) ◽

pp. 286-290 ◽

Cited By ~ 1

Author(s):

Yi Dong ◽

Jiazhi Qu ◽

Zhijun Zhang ◽

Changjun Wang ◽

Qiang Dong

Keyword(s):

Clinical Trial ◽

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Phase Iii ◽

Stroke Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Pooled Data

Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

American Journal of Clinical Dermatology ◽

10.1007/s40257-021-00638-z ◽

2021 ◽

Author(s):

Eric L. Simpson ◽

Jonathan I. Silverberg ◽

Audrey Nosbaum ◽

Kevin L. Winthrop ◽

Emma Guttman-Yassky ◽

...

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Phase Ii ◽

Safety Analysis ◽

Phase Iii ◽

Severe Atopic Dermatitis ◽

Clinical Trial Program

Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme

Diabetes Obesity and Metabolism ◽

10.1111/dom.12624 ◽

2016 ◽

Vol 18 (4) ◽

pp. 419-424 ◽

Cited By ~ 14

Author(s):

M. Yu ◽

K. Van Brunt ◽

O. J. Varnado ◽

K. S. Boye

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Patient Reported Outcome ◽

Phase Iii ◽

Patient Reported ◽

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta‐analysis of the liraglutide phase III clinical trial programme

Diabetes Obesity and Metabolism ◽

10.1111/dom.12617 ◽

2016 ◽

Vol 18 (7) ◽

pp. 707-710 ◽

Cited By ~ 4

Author(s):

E. Montanya ◽

V. Fonseca ◽

S. Colagiuri ◽

L. Blonde ◽

M. Donsmark ◽

...

Keyword(s):

Clinical Trial ◽

Body Mass Index ◽

Body Mass ◽

Meta Analysis ◽

Glycated Haemoglobin ◽

Phase Iii ◽

Baseline Body Mass Index ◽